Published in J Theor Biol on August 27, 2014
IMMUNOGENETIC CONSEQUENCES OF VASCULAR ANASTOMOSES BETWEEN BOVINE TWINS. Science (1945) 12.87
Chronic thyroiditis and autoimmunization. J Am Med Assoc (1957) 7.08
The somatic generation of immune recognition. Eur J Immunol (1971) 6.80
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell (1995) 5.82
Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (1988) 4.63
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04
Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01
Chlamydia infections and heart disease linked through antigenic mimicry. Science (1999) 3.73
PERSISTENCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN IMMUNE ANIMALS AND ITS RELATION TO IMMUNITY. J Exp Med (1936) 3.70
Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science (1985) 3.68
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
Negative selection of lymphocytes. Cell (1994) 3.47
Role of the microbiota in immunity and inflammation. Cell (2014) 3.43
Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science (1971) 3.31
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature (2014) 2.58
Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin Exp Immunol (1973) 2.55
Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol (1948) 2.53
Molecular mimicry and immune-mediated diseases. FASEB J (1998) 2.53
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology (2013) 2.14
Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12
Central tolerance: good but imperfect. Immunol Rev (2006) 1.86
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev (2006) 1.81
Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol (1971) 1.76
Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med (1977) 1.73
Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med (1992) 1.45
Molecular mimicry as a mechanism of autoimmune disease. Clin Rev Allergy Immunol (2012) 1.37
Streptococcus and rheumatic fever. Curr Opin Rheumatol (2012) 1.32
Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med (2014) 1.29
Studies on natural antibodies and autoantibodies. Ann Immunol (Paris) (1983) 1.27
Neonatal thymectomy increases spontaneous autoimmune thyroiditis. J Immunol (1973) 1.23
Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes. Immunol Cell Biol (2010) 1.22
Neonatal thymectomy increases the incidence of spontaneous and methylcholanthrene-enhanced thyroiditis in rats. Science (1974) 1.21
Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol (1995) 1.20
T-cell tolerance: exposure to virus in utero does not cause a permanent deletion of specific T cells. Proc Natl Acad Sci U S A (1988) 1.18
Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1. Front Immunol (2014) 1.18
Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J Exp Med (2012) 1.15
Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci (2000) 1.14
The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol (2008) 1.13
Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen. J Autoimmun (2013) 1.07
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
LPS promotes CB3-induced myocarditis in resistant B10.A mice. Cell Immunol (1991) 1.01
An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol (2004) 1.00
Virus infection, antiviral immunity, and autoimmunity. Immunol Rev (2013) 1.00
A reliable and safe T cell repertoire based on low-affinity T cell receptors. J Theor Biol (2001) 0.99
Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity. Hum Immunol (1997) 0.98
A novel model of drug hapten-induced hepatitis with increased mast cells in the BALB/c mouse. Exp Mol Pathol (2005) 0.97
Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today (1999) 0.93
The initiation and early development of autoimmune diseases. Clin Immunol Immunopathol (1988) 0.93
Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis. J Immunol (2014) 0.90
The many faces of aire in central tolerance. Front Immunol (2013) 0.90
The genetic lesions of autoimmunity. Clin Exp Immunol (1980) 0.89
Murine thyroiditis induced by neonatal thymectomy. Experientia (1973) 0.88
Relation between the major histocompatibility (B) locus and autoimmune thyroiditis in obese chickens. Science (1974) 0.88
Regulation of experimental autoimmune thyroiditis: influence of non-H-2 genes. J Immunogenet (1982) 0.86
Active clonal deletion in neonatal H-2 tolerance. Ann N Y Acad Sci (1982) 0.86
Good riddance: Thymocyte clonal deletion prevents autoimmunity. Curr Opin Immunol (2004) 0.84
Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse. Clin Exp Immunol (2005) 0.83
L.E.A.P.S. heteroconjugate is able to prevent and treat experimental autoimmune myocarditis by altering trafficking of autoaggressive cells to the heart. Int Immunopharmacol (2008) 0.83
Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 0.83
A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. J Autoimmun (2014) 0.82
Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate. J Immunol (2014) 0.81
Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun (2013) 0.81
Editorial: regulatory B cells: are we really ready to manipulate them for the benefit of patients with autoimmune diseases? Arthritis Rheumatol (2014) 0.81
Dendritic cells in tolerance and autoimmune diabetes. Curr Opin Immunol (2013) 0.80
Antigen-specific immunoregulation and autoimmune thyroiditis. Ann N Y Acad Sci (1991) 0.79
The lessons of vasectomy-a review. J Clin Lab Immunol (1980) 0.79
Characteristics of some "natural" autoantibodies in rabbits. J Immunol (1969) 0.78
Immune privilege and the philosophy of immunology. Front Immunol (2014) 0.78
The role of the thymus in spontaneous autoimmune thyroiditis. Ann N Y Acad Sci (1975) 0.76